Life Science Connect
Life Science Connect
  • 948
  • 89 395
What’s On The Horizon For KSQ?
KSQ is developing next-generation TIL therapies with support from MD Anderson and CTMC.
An excerpt from "The Anti-CDMO with CTMC's Jason Bock, Ph.D., and KSQ's Thomas Leitch" Check out the full video at www.bioprocessonline.com/doc/the-anti-cdmo-with-ctmc-s-jason-bock-ph-d-and-ksq-s-thomas-leitch-0001
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple.com/us/podcast/business-of-biotech/id1508008606?uo=4
Spotify - open.spotify.com/show/5NhjpDeHzVlXPVqT9ezKwA
TH-cam - th-cam.com/play/PLFXsCNKV78rWNPmqIA8b2dKYLPYYv28wb.html
มุมมอง: 1

วีดีโอ

Selecting A Manufacturing Partner
มุมมอง 32 ชั่วโมงที่ผ่านมา
According to KSQ’s Thomas Leitch, when it comes to selecting a manufacturing partner, company culture is as important as technological capabilities. An excerpt from "The Anti-CDMO with CTMC's Jason Bock, Ph.D., and KSQ's Thomas Leitch" Check out the full video at www.bioprocessonline.com/doc/the-anti-cdmo-with-ctmc-s-jason-bock-ph-d-and-ksq-s-thomas-leitch-0001 #businessofbiotech #biopharma #bi...
How CTMC And KSQ’s Partnership Is Accelerating TIL Research
มุมมอง 72 ชั่วโมงที่ผ่านมา
CTMC can be described as a boutique CDMO, but their relationship with KSQ is a true partnership that leverages MD Anderson’s experience with oncology research to take TIL therapies to the next level. An excerpt from "The Anti-CDMO with CTMC's Jason Bock, Ph.D., and KSQ's Thomas Leitch" Check out the full video at www.bioprocessonline.com/doc/the-anti-cdmo-with-ctmc-s-jason-bock-ph-d-and-ksq-s-t...
ADCs Ignited with Daiichi Sankyo's Ken Keller
มุมมอง 822 ชั่วโมงที่ผ่านมา
Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove nearly $100 billion in M&A, licensing, and partnership deals, and a Daiichi Sankyo that can rightfully lay claim to lighting that fire. In fact, it was our g...
How Generative AI Enhances Creativity In Biotech
มุมมอง 2214 ชั่วโมงที่ผ่านมา
AI and ML marry computational science to biology, creating new opportunities for biotech. An excerpt from "The AI Impact with Generate: Biomedicines' Mike Nally" Check out the full video at www.bioprocessonline.com/doc/the-ai-impact-with-generate-biomedicines-mike-nally-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/us/podcast/business-of-biotec...
What’s Next For Generate: Biosciences?
มุมมอง 1514 ชั่วโมงที่ผ่านมา
Mike Nally provides updates on his company’s current and future plans. An excerpt from "The AI Impact with Generate: Biomedicines' Mike Nally" Check out the full video at www.bioprocessonline.com/doc/the-ai-impact-with-generate-biomedicines-mike-nally-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/us/podcast/business-of-biotech/id1508008606?uo=4...
Is Financial Risk In Biotech Exaggerated?
มุมมอง 814 ชั่วโมงที่ผ่านมา
Mike Nally explains how Generate: Biomedicines has weathered the post-pandemic financial storm. An excerpt from "The AI Impact with Generate: Biomedicines' Mike Nally" Check out the full video at www.bioprocessonline.com/doc/the-ai-impact-with-generate-biomedicines-mike-nally-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/us/podcast/business-of-...
Why Generate: Biomedicines’ Mike Nally Left Merck To Lead Biotech’s AI Revolution
มุมมอง 1514 ชั่วโมงที่ผ่านมา
Mike Nally, former CMO of human health, says that developing medicine is harder than putting people on the moon, yet he remains optimistic for biotech’s future. An excerpt from "The AI Impact with Generate: Biomedicines' Mike Nally" Check out the full video at www.bioprocessonline.com/doc/the-ai-impact-with-generate-biomedicines-mike-nally-0001 #businessofbiotech #biopharma #biotech Subscribe t...
How Are Venture Philanthropists Helping Biotech Weather Economic Storms?
มุมมอง 2316 ชั่วโมงที่ผ่านมา
Biotech financing has experienced many ups and downs in recent years, but venture philanthropy provides an alternative investment model that safeguards scientific progress. An excerpt from "Funding Alzheimer's Tx Dev with ADDF's Karen Harris" Check out the full video at www.bioprocessonline.com/doc/funding-alzheimer-s-tx-dev-with-addf-s-karen-harris-0001 #businessofbiotech #biopharma #biotech S...
How ADDF Uses Venture Philanthropy To Support Alzheimer’s Research
มุมมอง 616 ชั่วโมงที่ผ่านมา
Karen Harris explains how ADDF partners with leading biotech companies to improve Alzheimer’s diagnostics and research. An excerpt from "Funding Alzheimer's Tx Dev with ADDF's Karen Harris" Check out the full video at www.bioprocessonline.com/doc/funding-alzheimer-s-tx-dev-with-addf-s-karen-harris-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/u...
ADDF’s Karen Harris On Mission-Related Investing
มุมมอง 716 ชั่วโมงที่ผ่านมา
ADDF’s venture philanthropy model is accelerating Alzheimer’s research through a uniqe investment strategy. An excerpt from "Funding Alzheimer's Tx Dev with ADDF's Karen Harris" Check out the full video at www.bioprocessonline.com/doc/funding-alzheimer-s-tx-dev-with-addf-s-karen-harris-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/us/podcast/bu...
The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley
มุมมอง 2716 ชั่วโมงที่ผ่านมา
Dr. Bambi Grilley is Professor of Pediatrics and the Director of Clinical Research and Early Product Development for the Center of Cell and Gene Therapy (CAGT) at Baylor College of Medicine AND she is Chief Regulatory Officer at ISCT. Dr. Grilley talks to us about her role as CRO at ISCT and the global regulatory landscape for cell and gene therapies. She takes a deep dive into the pediatric pa...
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
มุมมอง 12719 ชั่วโมงที่ผ่านมา
Mythic Therapeutics Chief Scientific Officer and Co-Founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experiences as an MIT Ph.D. student, a Flagship Ventures Fellow, a Bain consultant, a hospital researcher, and a biopharma consultant indiciative of a young man who di...
What’s Next For Ampersand Biomedicines?
มุมมอง 17วันที่ผ่านมา
Ampersand’s current pipeline and future plans leverage AL and ML to accelerate drug development. An excerpt from "Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil." Check out the full video at www.bioprocessonline.com/doc/precision-drug-delivery-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - podcasts.apple.com/us/podcast/business-of-biote...
Marrying Computational Biology To Biotech Science
มุมมอง 14วันที่ผ่านมา
Jason Gardner of Ampersand Biomedicines talks about building a team of computational biologists and forming partnerships in the current financial market. An excerpt from "Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil." Check out the full video at www.bioprocessonline.com/doc/precision-drug-delivery-0001 #businessofbiotech #biopharma #biotech Subscribe to the podcast...
How Can ML And AI Improve Drug Development Success Rates?
มุมมอง 10วันที่ผ่านมา
How Can ML And AI Improve Drug Development Success Rates?
Jason Gardner: From GSK To Ampersand Biomedicines CEO
มุมมอง 7วันที่ผ่านมา
Jason Gardner: From GSK To Ampersand Biomedicines CEO
Dr. Bruce Levine on ISCT and the Future of CAR-T
มุมมอง 67วันที่ผ่านมา
Dr. Bruce Levine on ISCT and the Future of CAR-T
Best Practices To Building And Funding A Successful CRISPR-Based Company
มุมมอง 25วันที่ผ่านมา
Best Practices To Building And Funding A Successful CRISPR-Based Company
Ups And Downs Of The Biotech Industry
มุมมอง 19วันที่ผ่านมา
Ups And Downs Of The Biotech Industry
Balancing Medical Practice, Biotech Leadership, and Venture Capital Advising
มุมมอง 6วันที่ผ่านมา
Balancing Medical Practice, Biotech Leadership, and Venture Capital Advising
What Are The Challenges To Running An RNA Biotech?
มุมมอง 3314 วันที่ผ่านมา
What Are The Challenges To Running An RNA Biotech?
What Are The Advantages Of Circular RNA?
มุมมอง 1314 วันที่ผ่านมา
What Are The Advantages Of Circular RNA?
How Orna Pioneered Circular RNA Drug Development
มุมมอง 814 วันที่ผ่านมา
How Orna Pioneered Circular RNA Drug Development
How Orna Therapeutics’ Tom Barnes Got Into RNA Drug Development
มุมมอง 1814 วันที่ผ่านมา
How Orna Therapeutics’ Tom Barnes Got Into RNA Drug Development
Best Bets For Biopharma R&D Efficiency
มุมมอง 1014 วันที่ผ่านมา
Best Bets For Biopharma R&D Efficiency
Faster Biopharma R&D: What Could Go Wrong?
มุมมอง 914 วันที่ผ่านมา
Faster Biopharma R&D: What Could Go Wrong?
Countdown To Patient Impact: How Fast Can We Go?
มุมมอง 1514 วันที่ผ่านมา
Countdown To Patient Impact: How Fast Can We Go?
What Biopharma R&D Steps Are Ripe For Efficiency Gains?
มุมมอง 2714 วันที่ผ่านมา
What Biopharma R&D Steps Are Ripe For Efficiency Gains?
Challenges To Greenlighting Biologics R&D
มุมมอง 514 วันที่ผ่านมา
Challenges To Greenlighting Biologics R&D

ความคิดเห็น

  • @jerm184
    @jerm184 7 ชั่วโมงที่ผ่านมา

    Why she sold

  • @okiedokie1238
    @okiedokie1238 3 หลายเดือนก่อน

    Is it possible to access this stream in it's entirety? This channel is a gem!

  • @lw1zfog
    @lw1zfog 3 หลายเดือนก่อน

    ‘For us, therefore, we’re really taking that leap - us as company, Bayer, in cell and gene therapy, which to me is one of these examples where really we’re going to make a difference, hopefully, moving forward. Ultimately the mRNA vaccines are an example for that - cell and gene therapy - I always like to say that if we had surveyed two years ago in the public, “would you be willing to take a gene or cell therapy and inject it into your body” - we would have had probably a 95% refusal rate. I think this pandemic has also opened many people’s eyes to innovation in a way that was maybe not possible before.’ - Bayer Executive Stefan Oelrich, in a speech at the World Health Summit, October 2021.

  • @Mr.Funny8484
    @Mr.Funny8484 4 หลายเดือนก่อน

    Biotech industry is engaged in production of only mAbs & earning money and not altering the microbiom.

  • @maxharmify
    @maxharmify 4 หลายเดือนก่อน

    GOOD JOB!

  • @darnellamero1168
    @darnellamero1168 5 หลายเดือนก่อน

    My son is off to sickkids hospital in Toronto in 2 weeks to receive his car-t cell treatment. He had ALL leukimia nearly 7 years ago and he relapsed. He is the the sweetest down syndrome kid you could ever meet. I can not thank Mr Carl June enough for giving us the oppurtunity to see our son live a normal life. If Dr. june and his team does not win a nobel prize for this, then the world needs a reset. This man is a God sent angel for sure. It would be a pleasure to shake this mans hand.

  • @alvares893
    @alvares893 9 หลายเดือนก่อน

    Gracias, esperamos pronto buenas noticias Afectado pde6a

  • @KarenLewis-mu1ud
    @KarenLewis-mu1ud ปีที่แล้ว

    Foreshadowing of his current vibrant presidential campaign.

  • @AdamBicycle
    @AdamBicycle ปีที่แล้ว

    Very on point questions, insightful.

  • @rakeshsharma-dz7so
    @rakeshsharma-dz7so ปีที่แล้ว

    hello sir thanks lot for this awesome conversation (jackpot of knowledge).

  • @southousee
    @southousee ปีที่แล้ว

    This really was completely useless

  • @BioMedUSA
    @BioMedUSA ปีที่แล้ว

    Very refreshing interview! Nice to hear a CEO of a biotech talk like a regular person excited about her company compared to these other CEO's I have listened to recently who drone on and sound like they are reading a script and a boring one at that. Dr. Sullivan sounds highly motivated and I can imagine it is / will be relatively easy for her to close future deals with large pharma. And her experience and great success with Springworks Therapeutics should engender confidence in her ability to run PYXS. PYXS presently trading at less than half of their cash value and looks to be an incredible bargain at the present stock price!

  • @FightBackAgainstDiabetes
    @FightBackAgainstDiabetes ปีที่แล้ว

    *You Did Not Choose To Be Classified As Diabetic, But You Can Choose To Fight Back Against Diabetes* 💪

    • @mehmetalikutlu3513
      @mehmetalikutlu3513 ปีที่แล้ว

      Cocuklara uygulanırmi ne kadar olur fiyatı sizce

    • @kingshuksahu5159
      @kingshuksahu5159 11 หลายเดือนก่อน

      Eai comment ta kora bandho kor baler...

  • @dexion12
    @dexion12 ปีที่แล้ว

    Incredibly great interview. Now a huge Cidera and Matt Pillar fan.

  • @FolakeBamigboye
    @FolakeBamigboye ปีที่แล้ว

    Times used to be very Challenging, I had the worst days of my life living with Type 2 diabetes, I appreciate you so much Dr Igudia, You have restored me my life that was lost already . Thank you so much for curing me of my diabetes with your natural Herbs 😊

  • @HotBodzLatino
    @HotBodzLatino ปีที่แล้ว

    I would really like to be a patient for this clinic trial as I am a T1D for 11 1/2 yrs

    • @durgabisheti1733
      @durgabisheti1733 ปีที่แล้ว

      How is the treatment? Are you satisfied of this treatment? Now are you independent from insulin injection? Please reply me it's very important

  • @xjsnjkil2070
    @xjsnjkil2070 ปีที่แล้ว

    Nothing is done since the interview. Telling story ain't cut it, it is time to execute it.

  • @SamEbby
    @SamEbby ปีที่แล้ว

    This dude said a whole lot of nothing . He can talk forever and say absolutely nothing

  • @barrybentley8066
    @barrybentley8066 ปีที่แล้ว

    No cure no cure no cure 😢

    • @nwc3270
      @nwc3270 ปีที่แล้ว

      They have a cure, 3 people are insulin free, 1 lady has been insulin free for over 2 years and counting, just have to get the fda to fast track what there doing

    • @jayalakshmi2959
      @jayalakshmi2959 ปีที่แล้ว

      Hi sir iam living to one of belive , iam counting for days when will stem cell cure diabets

  • @mikeliu3475
    @mikeliu3475 ปีที่แล้ว

    Congratulations Michelle and your team for the great achievements within the short period of time!

  • @TheAmitrajpurohit
    @TheAmitrajpurohit ปีที่แล้ว

    All the blessings and powers to you, God bless. All T1D people are going to thank and bless you throughout their lives.

  • @pihugupta6764
    @pihugupta6764 ปีที่แล้ว

    Which Hospital Available Stem cell therepy T1dibetes in India...

    • @savathi.v8139
      @savathi.v8139 ปีที่แล้ว

      Go to dr .sagar jawala jalgon mhararastra

  • @babayt3932
    @babayt3932 ปีที่แล้ว

    God help you, God help you, I saw that you are working for us with DT1, we are not living, we are surviving, dependent on the insulin that saved us, please, please, help, respect

  • @christinekho8832
    @christinekho8832 ปีที่แล้ว

    A very much oversold stock...IO102-103 with 3 years survival probability of >70%..this is much better than recently approved opduolag and nivo/ipi combo

  • @Jamesfoleyjr
    @Jamesfoleyjr ปีที่แล้ว

    silencing rnai is a Reversible and natural occurrence... homeostatic medicine. Silence, the abnormal protein and let the body heal itself.

  • @rj-fu8rz
    @rj-fu8rz ปีที่แล้ว

    It is nice to see this Nobel- prize winning technology leading to drugs….very promising!

  • @rosewillsonfred9752
    @rosewillsonfred9752 ปีที่แล้ว

    I want to Share This testimony. And also thanking God For Saving my life Through #DrAlaka Who Cures All kinds Of Deadly Virus. With is Gift Of Herbal remedy. Want to say a big thanks to you #DrAlaka for saving me from Anemia Virus that I have suffer for long Now with your herbal Remedy. God Bless you Sir. Add on TH-cam @ #drAlaka or through👉th-cam.com/channels/mkfwnFpXrrsHSxXmdgmCLg.html .....

  • @thunderdrumandbass
    @thunderdrumandbass ปีที่แล้ว

    this channel adds straight value. i wish i could listen live. thank you so much for uploading this

  • @paulhampel8084
    @paulhampel8084 ปีที่แล้ว

    I'm surprise this discussion viewed LNP mRNA as full mRNA only. Moderna's current Personalized Cancer Vaccine mRNA-4157 Phase 2 focuses on neoantigens cleaved by proteasome in the cell. The Neoantigen Protein Chain does not seem like a major size problem. I think this discussion was not very balanced. I see the value of Car-T and cas9 but I'm not sure they compete with LNP mRNA approaches that much.

  • @Mr.Moderator
    @Mr.Moderator ปีที่แล้ว

    They will get bought out or bleed out. Hope mgmt makes right decision here.

  • @phillyarrowood7868
    @phillyarrowood7868 ปีที่แล้ว

    ƤRO𝓂O𝕤ᗰ 🙂

  • @insidethemind434
    @insidethemind434 ปีที่แล้ว

    What is the name of that documentary?

  • @henrydamilola8801
    @henrydamilola8801 ปีที่แล้ว

    I have been dealing with HIV for the past 5 years until i got review on TH-cam about 🔍 Dr Abiola and I got Dr Abiola herbal medicine last month,I am so happy today that I am now HIV negative #drabiolahome.

  • @henrydamilola8801
    @henrydamilola8801 ปีที่แล้ว

    I have been dealing with HIV for the past 5 years until i got review on TH-cam about 🔍 Dr Abiola and I got Dr Abiola herbal medicine last month,I am so happy today that I am now HIV negative #drabiolahome.

  • @Frank020
    @Frank020 ปีที่แล้ว

    I'm Holden, but not golden. 🌝 . Let's moon this B word, my queens of the biosciences.💗...😁🌝

  • @user-um5lg9kc1g
    @user-um5lg9kc1g ปีที่แล้ว

    th-cam.com/video/K4pYemga4Cs/w-d-xo.html ?

  • @jasondavis2810
    @jasondavis2810 2 ปีที่แล้ว

    Great discussion

  • @Havana1975xx
    @Havana1975xx 2 ปีที่แล้ว

    Thank you great work

  • @craigmosolowski4663
    @craigmosolowski4663 2 ปีที่แล้ว

    I predict a Nobel Prize for Dr. Laura Niklason!

  • @luckyea7
    @luckyea7 2 ปีที่แล้ว

    The Russian Sputnik V vaccine demonstrates effective protection against the COVID-19 omicron strain and a higher antibody titer compared to two injections of the American Pfizer vaccine. This is evidenced by the results of a study by the Spallanzani Institute in Italy, the results of which were published in the medical journal Vaccines, the Gamaleya National Research Center for Epidemiology and Microbiology reported. It is known that the titer of virus-neutralizing antibodies to omicron in Sputnik V turned out to be 2.1 times higher in general and 2.6 times higher three months after vaccination. Thus, 74.2 percent of all blood serum samples vaccinated with the domestic drug neutralized omicron (against 56.9 percent from Pfizer). Experts found that Sputnik V generates a stronger response due to a wider range of virus-neutralizing antibodies, a heterogeneous vaccine scheme, and a higher degree of infection imitation by the adenoviral platform. It is noted that the study was conducted under equal laboratory conditions at the Spallanzani Institute on the basis of comparable serum samples from individuals vaccinated with Sputnik V and Pfizer with similar levels of IgG antibodies and virus-neutralizing activity to the original strain registered in Wuhan, China.

  • @alesbuxbaum9616
    @alesbuxbaum9616 2 ปีที่แล้ว

    The Ring Therapeutics has been facing many scientific challenges over the years in regards of generating the human anellovirus therapeutic vectors; human anelloviruses seem to be some kind of evolving viruses or week like viruses - anellovirueses do not have endogenous-own viral replicase proteins, a known DNA conserved origin of replication stem loop, and indeed they form very unstable capsid virions. The potential therapeutic payload of a recombinant TTMV-Anellovirus vector may be very limited around 2000bp in size. Here, we talk about a possibility of the first generation anellovirus vectors based on scientific academy papers published many years ago….

  • @David-tq9bi
    @David-tq9bi 2 ปีที่แล้ว

    HAHAAHAH f... your Ideas, you can not realize shit. You don't Value your Investors, 5 Times RS until now. Paying yourself astronomical Paychecks every year out and in 15 years Company achieved nothing!!!

  • @Imran-eo9vt
    @Imran-eo9vt 2 ปีที่แล้ว

    Reaching cure of Type 1 Diabetes will be great service for Humanity. Millions of people are waiting for cure.

  • @peachtree3382
    @peachtree3382 2 ปีที่แล้ว

    We want our money back after that RS!!! Don't deserve to steal our money to remain listed with NO results! Class action lawsuit incoming!

  • @Frank020
    @Frank020 2 ปีที่แล้ว

    Let's go guys ...

  • @save400
    @save400 2 ปีที่แล้ว

    Could this work for ALS

  • @save400
    @save400 2 ปีที่แล้ว

    Could this work for ALS?

  • @lar3848
    @lar3848 2 ปีที่แล้ว

    I'm investing my 10% to ibio for next 10 years

  • @surajsonkar2052
    @surajsonkar2052 2 ปีที่แล้ว

    How to daibities new clinical trails information medicine please help to human

  • @lar3848
    @lar3848 2 ปีที่แล้ว

    I wish they would show the ibio lab